Opinion
verabschiedet on 10/06/2009
Referenz:
INT/469-EESC-2009-1022Referral:
COM(2008) 663 final - 2008/0256 (COD)Rapporteur:
Plenartagung:
454 -
Jun 10, 2009 Jun 11, 2009
Arzneimittel
Displaying 21 - 25 of 25
Pages
Opinion
verabschiedet on 10/06/2009
Referenz:
INT/471-EESC-2009-1024Referral:
COM(2008) 665 final – 2008/0260 (COD)Rapporteur:
Plenartagung:
454 -
Jun 10, 2009 Jun 11, 2009
Opinion
verabschiedet on 10/06/2009
Referenz:
INT/470-EESC-2009-1023Referral:
COM(2008) 664 final – 2008/0257 (COD)Rapporteur:
Ms Sylvia Gauci (Employers - GR I / Malta)
Plenartagung:
454 -
Jun 10, 2009 Jun 11, 2009
Opinion
verabschiedet on 10/06/2009
Referenz:
INT/475-EESC-2009-1025Referral:
COM(2008) 662 final - 2008/0255 (COD)Rapporteur:
Plenartagung:
454 -
Jun 10, 2009 Jun 11, 2009
Opinion
Referenz:
ECO/515-EESC-2020-01536-00-01-PAC-TRA Referral:
COM(2020) 113 final 2020/0043 CODGeneral Rapporteur:
Bernd SCHLÜTER (Diversity Europe - GR III)
Downloads: